With an increasing number of longer-term survivors treated with chimeric antigen receptor (CAR) T-cell therapy for non-Hodgkin lymphoma (NHL), more research is needed to confirm its effects on ...
Despite its recognition for centuries as “the great imitator,” neurosyphilis remains a diagnostic challenge because of its wide spectrum of presentations. Here we describe 3 men with neurosyphilis in ...
A study of 227 individuals who experienced neurocognitive difficulties post COVID-19 infection—such as headaches, vertigo, balance dysregulation, changes in taste/smell, and brain fog—displayed a ...
Revised ICD-10-CM codes for neurocognitive disorders are now in effect, the American Psychiatric Association (APA) has announced The coding changes for major and mild neurocognitive disorders ...
Neurocognitive disorders, mild and major, include a group of conditions which were once all grouped under the umbrella term “dementia.” The conditions involve similar cognitive impairments and decline ...
Epigenetic age acceleration appears to be associated with worse neurocognitive function for those that survive childhood ...
Long-term survival after hematopoietic cell transplant has improved greatly due to advancements in transplant practice and care. Despite this, transplant recipients are a high-risk group for issues ...
Abbreviations: AeYA, adolescent and early young adult; NA, not applicable; SMN, second malignant neoplasm. Comparing AeYA survivors with non-AeYA survivors. Comparing AeYA survivors with siblings.
According to the World Health Organization (WHO), COVID-19 long-haulers are people who experience symptoms such as body ache, fatigue, shortness of breath, headache, difficulty concentrating, loss of ...
Neurocognitive disorders, mild and major, include a group of conditions which were once all grouped under the umbrella term “dementia.” The conditions involve similar cognitive impairments and decline ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results